Abstract |
S100B is a prognostic marker for malignant melanoma. Increasing S100B levels are predictive of advancing disease stage, increased recurrence, and low overall survival in malignant melanoma patients. Using S100B overexpression and shRNA(S100B) knockdown studies in melanoma cell lines, elevated S100B was found to enhance cell viability and modulate MAPK signaling by binding directly to the p90 ribosomal S6 kinase (RSK). S100B-RSK complex formation was shown to be Ca(2+)-dependent and to block ERK-dependent phosphorylation of RSK, at Thr-573, in its C-terminal kinase domain. Additionally, the overexpression of S100B sequesters RSK into the cytosol and prevents it from acting on nuclear targets. Thus, elevated S100B contributes to abnormal ERK/RSK signaling and increased cell survival in malignant melanoma.
|
Authors | Kira G Hartman, Michele I Vitolo, Adam D Pierce, Jennifer M Fox, Paul Shapiro, Stuart S Martin, Paul T Wilder, David J Weber |
Journal | The Journal of biological chemistry
(J Biol Chem)
Vol. 289
Issue 18
Pg. 12886-95
(May 02 2014)
ISSN: 1083-351X [Electronic] United States |
PMID | 24627490
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Multiprotein Complexes
- S100 Calcium Binding Protein beta Subunit
- S100B protein, human
- Threonine
- Ribosomal Protein S6 Kinases, 90-kDa
- Extracellular Signal-Regulated MAP Kinases
- Calcium
|
Topics |
- Blotting, Western
- Calcium
(metabolism)
- Cell Line, Tumor
- Cell Nucleus
(metabolism)
- Cell Survival
(genetics)
- Cytosol
(metabolism)
- Extracellular Signal-Regulated MAP Kinases
(metabolism)
- Humans
- Melanoma
(genetics, metabolism, pathology)
- Microscopy, Confocal
- Multiprotein Complexes
(metabolism)
- Mutation
- Phosphorylation
- Protein Binding
- RNA Interference
- Ribosomal Protein S6 Kinases, 90-kDa
(metabolism)
- S100 Calcium Binding Protein beta Subunit
(genetics, metabolism)
- Threonine
(metabolism)
|